Sort
1,049,261 grants matching “t cell”
Glycan Modulation of Inflammatory Responses
$2,436,664Ajit P Varki · University Of California, San Diego · P01 · FY2013 · HL
Cancer Center Support Grant
$2,436,664Benjamin G. Neel · New York University School Of Medicine · P30 · FY2015 · CA
The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort Study
$2,436,580Dana Dabelea · University Of Colorado Denver · UH3 · FY2019 · OD
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,436,444Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2011 · HL
CCR Collaborative Bioinformatics Resource
$2,436,364David Goldstein · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2021 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2023 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2022 · HL
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,436,318Murray Grossman · University Of Pennsylvania · P01 · FY2020 · AG
Glycoconjugates and Cardiovascular Disease
$2,436,266Gerald Warren Hart · Johns Hopkins University · P01 · FY2011 · HL
HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,436,123Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$2,436,063Berislav V Zlokovic · University Of Southern California · P01 · FY2019 · AG
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,436,054Paul M. Lieberman · Wistar Institute · P01 · FY2023 · CA
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2017 · CA
Modulation Of Neuronal Channels and Receptors in the Brain
$2,435,935Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Development and Validation of Therapy for Mucopolysaccharidosis III
$2,435,870Jill Wood · Phoenix Nest, Inc. · U44 · FY2022 · NS
Primate Core - Core D
$2,435,589J. Mark Cline · Duke University · U19 · FY2016 · AI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
$2,435,478Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · P01 · FY2017 · HL
Integrating innate and adaptive pathways in vaccine responses
$2,435,437Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2014 · AI
THERAPY OF AML
$2,435,347University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,435,234Oscar A. Carretero · Henry Ford Health System · P01 · FY2015 · HL
Simian Vaccine Evaluation Units
$2,435,221Mark Lewis · Bioqual, Inc. · N01 · FY2012 · AI
Synaptic integration and intrinsic firing properties of basal ganglia neurons
$2,435,033Zayd M Khaliq · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Light Microscopy Core
$2,434,980Christian Combs · National Heart, Lung, And Blood Institute · ZIC · FY2024 · HL
Biological Variation in Hemophilia
$2,434,893John S. Lollar · Emory University · U54 · FY2014 · HL